You are here: Industry Insights > Market News > Granules India gets board nod to raise foreign investment limit

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate

Neohesperidin

Advantame

Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench

Pharma and Food Grade, USP/FCC Neotame Sweetener E961

Trilobatin

Granules India gets board nod to raise foreign investment limit

financialexpressJuly 06, 2017

Tag: granules , foreign investment

Favorites

Granules India said its board has approved a proposal to increase the foreign investment limit in the company to 49 per cent.

The board of directors has agreed to increase the present limit of FII/ FPIs shareholding in the company to 49 per cent of the total paid-up equity share capital, Granules India said in a BSE filing.

However, it said, the decision would be subject to shareholders’ approval.

As on March 31, 2017, FPI holding in the company stood at 9.98 per cent. Other foreign nationals owned 0.06 per cent.

Previous:Zydus starts phase II trial of ZYAN1 for treating anaemia in patients with CKD

Next:Pain-free microneedle patch could help boost flu vaccination rates

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

Granules India gets board nod to raise foreign investment limit | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

You may like
More>>

Hot Melt Extruder Machine Twin Screw Plastic Granules Making Machine Double-sxrew Extruder Pharmaceu

1,3-dibromo-5,5-dimethylhydantoin DBDMH Granules CAS NO.77-48-5

1-bromo-3-chloro-5,5-dimethylhydantoin Granules BCDMH CAS NO. 32718-18-6

Azithromycin Granules 100mg, 250mg

Potassium Chloride Granules in sachet 1g/6g, 1.5g/10g

1,3-dichloro-5,5-dimethylhydantoin DCDMH Granules CAS 118-52-5

Compound salvia miltiorrhiza granules (Containing extract of Salviae Miltiorrhizae Radix et Rhizoma

Diminazene aceturate and Phenazone and Vitamin B granules for injection

lower price 97.5%~102.0% White to off-white,granules or powder Cefoxitin sodium

Diminazene aceturate and Phenazone granules for injection

Granules India gets board nod to raise foreign investment limit

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

You may likeMore>>

You may like
More>>